Latest News
Phase III ARISER study with RENCAREX: patient recruitment successfully completed

Latest Ad Hoc Announcement
WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE® (CA9-SCAN)

Annual General Meeting 2008 on 3 June 2008

Current Presentation as of June 2008

1st Quarter report 2008

Annual Report 2007

Meet WILEX!

2.-3.9.2008
Sal. Oppenheim's 3. European Healthcare Investors Conference in Frankfurt

23.-24.9.2008
Annual Biotech in Europe Investor Forum in Zurich
(by Zurich Sachs Associates)

Conference list